Collagen as biomaterial for medical application-drug delivery and scaffolds for tissue regeneration: A review

Biological Engineering

Volumn 2, Issue 2, 2010, Pages 63-88

  Mandal, A ^a   Panigrahi, S ^a   Zhang, C ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Biomaterial; Biomedical; Collagen; Drug delivery; Scaffolds

Indexed keywords

BIOMATERIALS; COLLAGEN; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; MEDICAL APPLICATIONS; SCAFFOLDS; TARGETED DRUG DELIVERY; TISSUE; TISSUE REGENERATION;

ANIMAL PROTEINS; BIOMEDICAL; BIOMEDICAL APPLICATIONS; DRUG DELIVERY SYSTEM; MEDICAL PRODUCTS; PHYSIO-CHEMICAL PROPERTIES; TISSUE REPAIR;

SCAFFOLDS (BIOLOGY);

ANIMALIA;

EID: 78651534350     PISSN: 19342799     EISSN: 19342837     Source Type: Journal    
DOI: 10.13031/2013.32719     Document Type: Review

References (172)

1. Adeyemo, W. L., T. Reuther, W. Bloch, Y. Korkmaz, J. H. Fischer, J. E. Zoller, A. C. Kuebler. 2008. Healing of onlay mandibular bone grafts covered with collagen membrane or bovine bone substitutes: A microscopical and immunohistochemical study in the sheep. Intl. J. Oral Maxillofac. Surg. 37(7):651-659.
2. Aishwarya, S., S. Mahalakshmi, and P. K. Sehgal. 2008. Collagen-coated polycaprolactone microparticles as a controlled drug delivery system. J. Microencapsulation 25(5):298-306.
3. Akamaru, T., D. Suh, S. D. Boden, H. Kim, A. Minamide, and J. L. Ugbo. 2003. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 28(5):429-434.
4. Balasubramani, M., T. R. Kumar, and M. Babu. 2001. Skin substitutes: A review. Burns 27(5):534-544.
5. Barr, E., and J. M. Leiden. 1991. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254(5037):1507-1509.
6. Bedran-Russo, A. K. B., P. N. R. Pereira, W. R. Duarte, J. L. Drummond, and M. Yamauchi. 2007. Application of crosslinkers to dentin collagen enhances the ultimate tensile strength. J. Biomed. Mater. Res. B 80(1):268-272.
7. Belbachir, K., R. Noreen, G. Gouspillou, and C. Petibois. 2009. Collagen types analysis and differentiation by FTIR spectroscopy. Anal. Bioanal. Chem. 395(3):829-837.
8. Bell, E., S. Sher, B. Hull, C. Merril, S. Rosen, A. Chamson, D. Asselineau, L. Dubetret, B. Coulomb, C. Lapiere, B. Nusgens, and K. Neveux. 1983. The reconstitution of living skin. J. Invest. Dermatol. 81 (1 supp.): 2-10.
9. Bender, A., H. Von Briesen, J. Kreuter, I. B. Duncan, and H. Rubsamen-Waigmann. 1996. Efficiency of nanoparticles as a carrier system for antiviral agents in human monocytes/macrophages in vitro. Antimicrob. Agents Chemother. 40(6):1467-1471.
10. Berthold, A., K. Cremer, and J. Kreuter. 1998. Collagen microparticles: Carriers for glucorticosteroids. European J. Pharm. Biopharm. 45(1):23-49.
11. Bessa, P. C., M. Casal, and R. L. Reis. 2008. Bone morphogenetic proteins in tissue engineering: The road from laboratory to clinic: Part II. BMP delivery. J. Tissue Eng. Regen. Med. 2 (2-3): 81-96.
12. Biondi, M., F. Ungaro, F. Quaglia, and P. A. Netti. 2008. Controlled drug delivery in tissue engineering. Adv. Drug Deliv. Rev. 60(2):229-242.
13. Black, J. 1992. Biological Performance of Materials: Fundamentals of Biocompatibility. New York, N. Y.: Marcel Dekker.
14. Black, J., and G. W. Hastings. 1998. Handbook of Biomaterials Properties. London, U. K.: Chapman and Hall.
15. Bloomfield, S. E., T. Miyata, M. W. Dumn, N. Bueser, K. H. Stenzel, and A. L. Rubin. 1978. Soluble gentamycin ophthalmic inserts as a drug delivery system. Arch. Ophthalmol. 96(5):885-887.
16. Boden, S., J. L. Ugbo, C. Oliver, and A. Briest. 2005. Osseogenetic collagen complex as an effective graft alternative in experimental posterolateral lumbar spine arthrodesis. European Cells and Mater. 10 (supp. 3):51.
17. Bonassar, L. J., and C. A. Vacanti. 1998. Tissue engineering: the first decade and beyond. J. Cell Biochem. 72 (S30-31): 297-303.
18. Boyce, S. T. 1998. Skin substitutes from cultured cells and collagen-GAG polymers. Med. Biol. Eng. Comput. 36(6):791-800.
19. Boyce, S. T., M. J. Groretsky, D. G. Greenhalgh, R. J. Kagan, M. T. Rioeman, and G. D. Warden. 1995. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann. Surg. 222(6):743-752.
20. Bradley, W. G., and G. L. Wilkes. 1977. Some mechanical property considerations of reconstituted collagen for drug release supports. Biomater. Med. Dev. Artif. Organs 5(2):159-175.
21. Bu, H. Z., H. J. Gukasyan, L. Goulet, X. J. Lou, C. Xiang, and T. Koudriakova. 2007. Ocular disposition, pharmacokinetics, efficacy, and safety of nanoparticle-formulated ophthalmic drugs. Curr. Drug Metab. 8(2):91-107.
22. Bunyaratavej, P., and H. L. Wang. 2001. Collagen membranes: A review. J. Periodontol. 72(2):215-229.
23. Burgeson, R. E., and M. E. Nimni. 1992. Collagen types: Molecular structure and tissue distribution. Clin. Orthop. Relat. Res. 282:250-272.
24. Burkus, J. K., J. D. Dorchak, and D. L. Sanders. 2003. Radiographic assessment of inter body fusion using recombinant human bone morphogenetic protein type 2. Spine 28(4):372-377.
25. Cars, O., L. D. Hogberg, M. Murray, O. Nordberg, S. Sivaraman, C. S. Lundberg, A. D. So, and G. Tomson. 2008. Meeting the challenge of antibiotic resistance. BMJ 337 (): a1438.
26. Chevallay, B., and D. Herbage. 2000. Collagen-based biomaterials as 3D scaffold for cell cultures: Applications for tissue engineering and gene therapy. Med. Biol. Eng. Comput. 38(2):211-218.
27. Cochran, D. L., A. A. Jones, L. C. Lilly, J. P. Fiorellini, and H. Howell. 2000. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J. Periodontol. 71(8):1241-1257.
28. Compton, C. C., C. E. Butler, I. V. Yannas, G. Warland, and D. P. Orgill. 1998. Organized skin structure is regenerated in vivo from collagen-GAG matrices seeded with autologous keratinocytes. J. Invest. Dermatol. 110(6):908-916.
29. Cook, S. D., M. W. Wolfe, S. L. Salkeld, and D. C. Rueger. 1995. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J. Bone Joint Surg. (American) 77(5):734-750.
30. Cornell, C. N., J. M. Lane, D. Seligson, M. Chapman, S. Henry, K. Vincent, R. Merkow, and R. Gustilo. 1991. Multicenter trial of Collagraft as bone graft substitute. J. Orthop. Trauma 5(1):1-8.
31. Courvalin, P., and F. Depardieu. 2000. The influence of antibacterial mechanisms of action on the emergence, dissemination, and prevention of resistance. Ochsner Clin. Symp. Resist use Misuse Antimicrob. 136 (supp. 3):15-22.
32. Curran, M. P., and G. L. Polsker. 2002. Bilayered bioengineered skin substitute (Apligraf): A review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. Biodrugs. 16(6):439-455.
33. Deatherage, J. R., and E. J. Miller. 1987. Packaging and delivery of bone induction factors in a collagenous implant. Collagen Rel. Res. 7(3):225-231.
34. Doillon, C. J. 1987. Porous collagen sponge wound dressings: In vivo and vitro studies. J. Biomater Appl. 2(4):562-577.
35. Doillon, C. J., C. F. Whyne, S. Brandwein, and F. H. Silver. 1986. Collagen-based wound dressings: Control of the pore structure and morphology. J. Biomed. Mater. Res. 20(8):1219-1228.
36. Donati, D., C. di Bella, E. Lucarellia, B. Dozzaa, T. Frisonia, N. Nicoli Aldini, and R. Giardino. 2008. OP-1 application in bone allograft integration: Preliminary results in sheep experimental surgery. Injury Int. J. Care Injured 39 (supp. 2): S65-S72.
37. El-Sabban, M. E., H. El-Khoury, R. Hamdan-Khalil, S. Pedersen, and A. Bazarbachi. 2007. Xenogenic bone matrix extracts induce osteoblastic differentiation of human bone marrowderived mesenchymal stem cells. Regen. Med. 2(4):383-390.
38. El-Samaligy, M. S., and P. Rohdewald. 1983. Reconstituted collagen nanoparticles, a novel drug carrier delivery system. J. Pharm. Pharmacol. 35(8):537-539.
39. Flanagan, T. C., B. Wilkins, A. Black, S. Jockenhoevel, T. J. Smith, and A. S. Pandit. 2006. A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications. Biomaterials 27(10):2233-2246.
40. Fonseca, M. J., M. A. Alsina, and F. Reig. 1996. Coating liposomes with collagen (Mr 50000) increases uptake into liver. Biochim. Biophys. Acta 1279(2):259-265.
41. Friess, W. 1998. Collagen: Biomaterial for drug delivery. European J. Pharm. Biopharm. 45(2):113-136.
42. Friess, W. 2000. Drug Delivery Systems Based on Collagen. Aachen, Germany: Shaker Verlag.
43. Gautschi, O. P., S. P. Frey, and R. Zellweger. 2007. Bone morphogenetic proteins in clinical applications. ANZ J. Surg. 77(8):626-631.
44. Gebhardt, B. M., and H. E. Kaufman. 1995. Collagen as a delivery system for hydrophobic drugs: Studies with cyclosporine. J. Ocul. Pharmacol. Ther. 11(3):319-327.
45. Gebhardt, B. M., E. D. Varnell, and H. E. Kaufman. 1995. Cyclosporine in collagen particles: Corneal penetration and suppression of allograft rejection. J. Ocul. Pharmacol. Ther. 11(4):509-517.
46. Geesink, R. G. T., N. H. M. Hoefnagels, and S. K. Bulstra. 1999. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J. Bone Joint Surg. (British) 81-B (4):710-718.
47. Geiger, M., R. H. Li, and W. Friess. 2003. Collagen sponges for bone regeneration with rhBMP-2. Adv. Drug Deliv. Rev. 55(12):1613-1629.
48. Geller, J. H. 1958. Metabolic significance of collagen in tooth structure. J. Dent. Res. 37(2):276-281.
49. Gemmell, C. G., S. D. Gorham, M. J. Monsour, F. McMillan, and R. Scott. 1988. The in-vitro assessment of a collagen/vicryl (polyglactin) composite film together with candidate suture materials for potential use in urinary tract surgery. Urol. Res. 16(5):381-384.
50. Germain, L., P. Carrier, A. Francois, C. Salesse, and S. L. Guerin. 2000. Can we produce a human corneal equivalent by tissue engineering? Progr. Retin. Eye Res. 19(5):497-527.
51. Giannoudis, P. V., and C. Tzioupis. 2005. Clinical applications of BMP-7: The UK perspective. Injury 36 (3 supp.): S47-S50.
52. Greenwald, Y., and G. Kleinmann. 2008. Use of collagen shields for ocular-surface drug delivery. Expert Rev. Ophthalmol. 3(6):627-633.
53. Hariprasad, S. M., K. J. Blinder, G. K. Shah, R. S. Apte, B. Rosenblatt, N. M. Holekamp, M. A. Thomas, W. F. Mieler, J. Chi, and R. A. Prince. 2005a. Penetration pharmacokinetics of topically 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch. Ophthalmol. 123(1):39-44.
54. Hariprasad, S. M., G. K. Shah, J. Chi, and R. A. Prince. 2005b. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. J. Cataract Refract. Surg. 31(11):2142-2146.
55. Harringer, M. D., A. P. Supp, G. D. Warden, and S. T. Boyce. 1997. Glutaraldehyde crosslinking of collagen substrates inhibits degradation in skin substitutes grafted to athymic mice. J. Biomed. Mater. Res. A 35(2):137-145.
56. Harrison, K. W. 1989. Collagen corneal shields: An important therapeutic modality. J. Ophthal. Nurs. Tech. 8(3):97-98.
57. Haugen, B., L. Werner, N. Romaniv, J. Haymore, G. Kleinmann, N. Mamalis, J. Randall, and J. Olson. 2008. Prevention of endophthalmitis by collagen shields presoaked in fourthgeneration fluoroquinolones versus by topical prophylaxis. J. Cataract Refract. Surg. 34(5):853-858.
58. He, W., T. Yong, W. E. Teo, Z. Ma, and S. Ramakrishna. 2005. Fabrication and endothelialization of collagen-blended nanofibers: Potential vascular graft for blood vessel tissue engineering. Tissue Eng. 11 (9-10): 1574-1587.
59. Hirai, J., and T. Matsuda. 1996. Venous reconstruction using hybrid vascular tissue composed of vascular cells and collagen tissue regeneration process. Cell Transplant. 5(1):93-105.
60. Hong, Y., C. Gao, Y. Xie, Y. Gong, and J. Shen. 2005. Collagen-coated polylactide microspheres as chondrocyte microcarriers. Biomaterials 26(32):6305-6313.
61. Hou, Z., Q. Sun, Q. Wang, J. Han, Y. Wang, and Q. Zhang. 2009. In vitro and in vivo evaluation of novel implantable collagen-chitosan-soybean phosphatidylcholine composite film for the sustained delivery of mitomycin C. Drug Develop. Res. 70(3):206-213.
62. Huffer, W. E., J. J. Benedict, R. Rettenmaier, and A. Briest. 2006. Osteoinduction with Colloss, Colloss E, and GFm. In Tissue Engineering, 87-100. Advances in Experimental Medicine and Biology, vol. 585. J. P. Fisher, ed. New York, N. Y.: Springer.
63. Huffer, W. E., J. J. Benedict, A. S. Turner, A. Briest, R. Rettenmaier, M. Springer, and X. F. Walboomers. 2007. Repair of sheep long bone cortical defects filled with Colloss, Colloss E, Ossaplast, and fresh lilac crest autograft. J. Biomed Mater. Res. B 82(2):460-470.
64. Ipsen, T., P. S. Jorgensen, V. Damholt, and C. Tørholm. 1991. Gentamicin-collagen sponge for local applications. Acta Orthop. (Scandinavia) 62(6):592-594.
65. Iwai, S., Y. Sawa, H. Ichikawa, S. Taketani, E. Uchimura, G. Chen, M. Hara, J. Miyake, and H. Matsuda. 2004. Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prothesis. J. Thorac. Cardiovasc. Surg. 128(3):472-479.
66. Jorgensen, L. G., T. S. Sorensen, and J. E. Lorentzen. 1991. Clinical and pharmacokinetic evaluation of gentamicin containing collagen in groin wound infections after vascular reconstruction. European J. Vasc. Surg. 5(1):87-91.
67. Kanakaris, N. K., G. M. Calori, R. Verdonk, P. Burssens, P. de Biase, R. Capanna, L. B. Vangosa, P. Cherubino, F. Baldo, J. Ristiniemi, G. Kontakis, and P. V. Giannaoudis. 2008. Application of BMP-7 to tibial non-unions: A 3-year multicenter experience. Injury 39 (supp. 2): S83-S90.
68. Kassab, M. M., and R. E. Cohen. 2002. Treatment of gingival recession. J. American Dent. Assoc. 133(11):1499-1506.
69. Kaufman, H. E. 1988. Collagen shield symposium. J. Cataract Refractive Surg. 14(5):487-488.
70. Kaufman, H. E. 1989. Ophthalmic drug delivery system containing bioreodible polymers. U. S. Patent No. 4, 865, 846.
71. Kaufman, H. E., T. L. Steinemann, E. Lehman, H. W. Thompson, E. D. Varnell, J. T. Jacob-La Barre, and B. M. Gerhardt. 1994. Collagen-based drug delivery and artificial tears. J. Ocul. Pharmacol. 10(1):17-27.
72. Kearns, V. R., and R. L. Williams. 2009. Drug delivery systems for the eye. Expert Rev. Med. Devices 6: (3) 277-290.
73. Kim, B. S., C. E. Baez, and A. Atala. 2000. Biomaterials for tissue engineering. World J. Urol. 18(1):2-9.
74. Kleinmann, G., S. Larson, I. M. Neuhann, A. C. Hunold, R. LeBover, S. Hickman, N. Mamalis, and R. J. Olson. 2006. Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields. Cornea 25(2):209-213.
75. Koide, M., K. Osaki, J. Konishi, K. Oyamada, T. Katakura, A. Takahashi, and K. Yoshizato. 1993. A new type of biomaterial for artificial skin: Dehydrothermally cross-linked composites of fibrillar and denatured collagens. J. Biomed. Mater. Res. 27(1):79-87.
76. Kraiwattanapong, C., S. D. Boden, J. Louis-Ugbo, E. Attallah, B. Barnes, and W. C. Hutton. 2005. Comparison of Healos/bone marrow to INFUSE (rh-BMP-2/ACS) with a collagenceramic sponge bulking agent as graft substitutes for lumbar spine fusion. Spine 30(9):1001-1007.
77. Kubo, K. 2003. Characterization of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J. Artif. Organs 6(2):138-144. (Pubitemid 36829956)
78. Kuroyanagi, Y., M. Kenmochi, S. Ishihara, A. Takeda, A. Shiraishi, N. Ootake, E. Uchinuma, K. Torikai, and N. Shioya. 1993. A cultured skin substitute composed of fibroblasts and keratinocytes with a collagen matrix: Preliminary results of clinical trials. Ann. Plast. Surg. 31(4):340-351.
79. Lam, P. K., E. S. Y. Chan, C. T. Liew, C. H. Lau, S. C. Yen, and W. W. K. King. 1999. The efficacy of collagen dermis membrane and fibrin on cultured epidermal graft using an athymic mouse model. Ann. Plast. Surg. 43(5):523-528.
80. Leaders, F. E., G. Hecht, and M. VanHoose. 1973. New polymers in drug delivery. Ann. Ophthalmol. 5(5):513-522.
81. Lee, C. H., A. Singla, and Y. Lee. 2001a. Biomedical applications of collagen. Intl. J. Pharmaceutics 221:1-22.
82. Lee, J. E., J. C. Park, J. G. Kim, and H. Suh. 2001b. Preparation of collagen modified hyaluronan microparticles as antibiotics carrier. Yonsei Med. J. 42(3):291-298.
83. Lefebvre, F., S. Gorecki, R. Bareilli, J. Amedee, L. Bordenave, and M. Rabaud. 1992. New artificial connective matrix-like structure made of elastin solubilized peptides and collagens: Elaboration, biochemical, and structural properties. Biomaterials 13(1):28-33.
84. Lefebvre, F., P. Pilet, N. Bonzon, G. Daculsi, and M. Rabaud. 1996. New preparation and microstructure of the Endo-Patch elastin-collagen containing glycosaminoglycans. Biomaterials 17(18):1813-1818.
85. Leipziger, L. S., V. Glushko, B. Dibernado, F. Shafaie, J. Noble, J. Nichols, and O. M. Alvarez. 1985. Dermal wound repair: Role of collagen matrix implants and synthetic polymer dressings. J. American Acad. Dermatol. 12(2):409-419.
86. Levine, J. M., R. J. Noecker, L. C. Lane, L. Herrygers, D. Nix, and R. W. Snyder. 2004. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J. Cataract Refract. Surg. 30(10):2177-2182.
87. L'Heureux, N., S. Paquet, R. Labbe, L. Germain, and F. A. Auger. 1998. A completely biological tissue-engineered human blood vessel. FASEB J. 12(1):47-56.
88. Li, H., M. Springer, X. Zou, A. Briest, and C. Bunger. 2006. Ectopic bone induction by equine bone protein extract. Adv. Exp. Med. Biol. 585:393-402.
89. Li, H., X. Zou, M. Springer, A. Briest, M. Lind, and C. Bunger. 2007. Instrumented anterior lumbar interbody fusion with equine bone protein extract. Spine 32(4):126-129.
90. Liang Z. H., C. R. Zhou, C. P. Lin, A. H. Hong, and G. Q. Li. 2006. Influence of chitosan, collagen, collagen/chitosan films on red blood cells. Polymer Mater. Sci. Eng. 22:161-164.
91. Lietman, S. A., N. Inoue, B. Rafiee, L. W. Deitz, and E. Y. S. Chao. 2005. The effect of recombinant human osteogenic protein-1 on allograft incorporation. J. Bone Joint Surg. (British) 87-B (9):1292-1297.
92. Lima, C. G. A., R. S. de Oliveira, S. D. Figueiro, C. F. Wehmann, J. C. Goes, and A. S. B. Sombra. 2006. DC conductivity and dielectric permitivity of collagen-chitosan films. Mater. Chem. Phys. 99 (2-3): 284-288.
93. Lode, A., A. Bernhardt, K. Kroonen, M. Sringer, A. Briest, and M. Gelinsky. 2009. Development of a mechanically stable support for the osteoinductive biomaterial Colloss E. J. Tissue Eng. Regen. Med. 3(2):149-152.
94. Lynn, A. K., I. V. Yannas, and W. Bonfield. 2004. Antigenicity and immunogenicity of collagen. J. Biomed. Mater. Res. B 71(2):343-354.
95. Maeda, M., S. Tani, A. Sano, and K. Fujioka. 1999. Microstructure and release characteristics of the minipellet, a collagen-based drug delivery system for controlled release of protein drugs. J. Controlled Rel. 62(3):313-324.
96. Marty, J. J., R. C. Openheim, and P. Speiser. 1978. Nanoparticles: A new colloidal drug delivery system. Pharm. Acta Helv. 53(1):17-23.
97. Mather R., L. M. Karenchak, E. G. Romanowski, and R. P. Kowalski. 2002. Fourth-generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics. American J. Ophthalmol. 133(4):463-466.
98. Matsuda, T., T. Kitamura, H. Iwata, H. Takano, and T. Akutsu. 1988. A hybrid artificial vascular graft based upon an organ reconstruction model. Trans. American Soc. Artif. Intern. Organs 34(3):640-643.
99. McPherson, J. M., S. Sawamura, and R. Amstrong. 1986. An examination of the biologic response to injectable, glutaraldehyde cross-linked collagen implants. J. Biomed. Mater. Res. 20(1):93-107.
100. Minabe, M., K. Takeuchi, K. Tamura, T. Hori, and T. Umemoto. 1989. Subgingival administration of tetracycline on a collagen film. J. Periodontol. 60(10):552-556.
101. Miyata, T., T. Taira, and Y. Noishiki. 1992. Collagen engineering for biomaterial use. Clin. Mater. 9 (3-4): 139-148.
102. Mondino, B. J. 1991. Collagen shields. American J. Ophthalmol. 112(5):587-590.
103. Monsour, M. J., R. Mohammed, S. D. Gorham, D. A. French, and R. Scott. 1987. An assessment of a collagen/vicryl composite membrane to repair defects of the urinary bladder in rabbits. Urol. Res. 15(4):235-238. (Pubitemid 18084760)
104. Murata, M., B. Z. Haung, S. Imai, N. Nagai, and M. Arisue. 1999. Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone. Intl. J. Oral Maxillofac. Surg. 28(3):232-237.
105. Nakabayashi, N. 1985. Bonding of restorative materials to dentine: The present status in Japan. Intl. Dent. J. 35(2):145-154.
106. Nastruzzi, C., C. Pastesini, R. Cortesi, E. Esposito, R. Gambari, and E. Mengatti. 1994. Production and in vitro evaluation of gelatine microspheres containing an antitumor tetraamide. J. Microencapsulation 11(3):249-260.
107. Nienhuijs, M. E., X. F. Walboomers, and M. A. Merkx. 2006. Bone-like tissue formation using an equine Colloss e filled titanium scaffolding material. Biomaterials 27(16):3109-3114.
108. Ohkawa, K., S. Hayashi, N. Kameyama, H. Yamamoto, M. Yamaguchi, S. Kimoto, S. Kurata, and H. Shinji, 2009. Synthesis of collagen-like sequential polypeptides containing ophospho-L-hydroxyproline and preparation of electrospun composite fibers for possible dental application. Macromol. Biosci. 9(1):79-92.
109. Oner, L., and M. J. Groves. 1993. Optimization of conditions for preparing 2-to 5-micron range gelatin microparticles by using chilled dehydration agents. Pharm. Res. 10(4):621-626.
110. Ottani, V., M. Raspanti, and A. Ruggeri. 2001. Collagen structure and functional implications. Micron 32(3):251-260.
111. Pachence, J. M. 1996. Collagen-based devices for soft tissue repair. J. Biomed. Mater. Res. 33(1):35-40.
112. Pachence, J. M., R. A., Berg, and F. H. Silver. 1987. Collagen: Its place in the medical device industry. Med. Device Diagn. Ind. 9(1):49-55.
113. Park, H., M. Radisic, J. Lim, H. Chang, and G. Vunjak-Novakovic. 2005. A novel composite scaffold for cardiac tissue engineering. In Vitro Cell Dev. Biol. 41(7):188-196.
114. Patino, M. G., M. E. Neiders, S. Andreana, B. Noble, and R. E. Cohen. 2002. Collagen as implantable material in medicine and dentistry. J. Oral Implant. 28(5):220-225.
115. Paul, R. G., and A. J. Bailey. 2003. Chemical stabilization of collagen as a biomimetic. Scientific World J. 3:138-155.
116. Pluhar, G. E., A. S. Turner, A. R. Pierce, C. A. Toth, and D. L. Wheeler. 2006. A comparison of two biomaterial carriers for osteogenic protein-1 (BMP-7) in an ovine critical defect model. J. Bone Joint Surg. 88(7):960-966.
117. Poynton, A. R., and J. M. Lane. 2002. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27 (supp. 16): S40-S48.
118. Profio, A. E. 1993. Biomedical Engineering. New York, N. Y.: John Wiley and Sons.
119. Ramakrishna, S., J. Mayer, E. Wintermantel, and K. W. Leong. 2001. Biomedical application of polymer-composite materials: A review. Comp. Sci. Tech. 61(9):1189-1224.
120. Ratcliffe, J. H., I. M. Hunneyball, A. Smith, C. G. Wilson, and S. S. Davis. 1984. Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs. J. Pharm. Pharmacol. 36(7):431-436.
121. Rossler, B. 1993. Entwicklung und untersuchung von kollagenmikropartikeln als wirkstofftrager in hydrogelen am beispiel all-trans retinol. PhD diss. Frankfurt, Germany: University of Frankfurt.
122. Rossler, B., J. Kreuter, and D. Scherer. 1995. Collagen microparticles: Preparation and properties. J. Microencapsulation 12(1):49-57.
123. Rossler, B., J. Kreuter, and G. Ross. 1994. Effect of collagen microparticles on the stability of retinol and its absorption into hairless mouse skin in vitro. Pharmazie 49 (2-3): 175-179.
124. Rubin, A. L., K. H. Stenzel, T. Miyata, M. J. White, and M. Dunn. 1973. Collagen as a vehicle for drug delivery: Preliminary report. J. Clin. Pharmacol. 13(8):309-312.
125. Ruszczak, Z., and W. Friess. 2003. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv. Drug Del. Rev. 55(12):1679-1698.
126. Rutten, H. J. T., and P. H. A. Nijhuis. 1997. Prevention of wound infection in elective colorectal surgery by local application of a gentamicin-containing collagen sponge. European J. Surg. 163 (supp. 578):31-35.
127. Salkeld, S. L., L. P. Patron, R. L. Barrack, and S. Cook. 2001. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J. Bone Joint Surg. (American) 83-A (6):803-816.
128. Sastry, T. P., and P. K. Rao. 1991. Chapter 11: Chemically modified collagenous amniotic layer as a wound dressing material. In High-Performance Biomaterials: A Complete Guide to Medical and Pharmaceutical Applications. M. Szycher, ed. Lancaster, Pa.: Technomic Publishing.
129. Sato, H., H. Kitazawa, I. Adachi, and I. Horikoshi. 1996. Microdialysis assessment of microfibrous collagen containing a p-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etopocide. Pharm. Res. 13(10):1565-1569.
130. Scabbia, A, and L. Trombelli. 2004. A comparative study on the use of a HA/collagen/chondroitin sulfate biomaterial (Biostites) and a bovine-derived HA xenograft (Bio-Oss) in the treatment of deep intra-osseous defects. J. Clin. Periodontol. 31(5):348-355.
131. Scharfmann, R., J. H. Axelord, and I. M. Verma. 1991. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. 88(11):4626-4630.
132. Schlapp, M., and W. Friess. 2003. Collagen/PLGA microparticle composites for local controlled delivery of gentamicin. J Pharm. Sci. 92(11):2145-2151.
133. Schlegel, K. A., K. Donath, S. Rupprecht, S. Falk, R. Zimmermann, E. Felszeghy, and J. Wiltfang. 2004. De novo formation using bovine collagen and platelet-rich plasma. Biomaterials 25(23):5387-5393.
134. Schoof, H., J. Apel, I. Heschel, and G. Rau. 2001. Control of pore structure and size in freezedried collagen sponges. J. Biomed. Mater. Res. B 58(4):352-357.
135. Seeherman, H., and J. M. Wozney. 2005. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16: (3) 329-345.
136. Sehgal, P. K., and A. Srinivasan. 2009. Collagen-coated microparticles in drug delivery. Expert Opin. Drug Deliv. 6(7):687-695.
137. Senta, H., H. Park, E. Bergeron, O. Drevelle, D. Fong, E. Leblanc, F. Cabana, S. Roux, G. Grenier, and N. Faucheux. 2009. Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations. Cytokine Growth Factor Rev. 20(3):213-222.
138. Sheridan, R. L., and R. G. Tompkins. 1999. Skin substitutes in burns. Burns 25(2):97-103.
139. Shoulders, M. D., and R. T. Raines. 2009. Collagen structure and stability. Ann. Rev. Biochem. 78:929-958.
140. Simpson, D. G., L. Terracio, M. Terracio, R. L. Price, D. C. Turner, and T. K. Borg. 1994. Modulation of cardiac myocyte phenotype in vitro by the composition and orientation of the extracellular matrix. J. Cell. Physiol. 161(1):89-105.
141. Solomon, R., E. D. Donnnenfeld, H. D. Perry, R. W. Synder, C. Nedrud, J. Stein, and A. Bloom. 2005. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 112(3):466-469.
142. Sorensen, T. S., A. I. Sorensen, and S. Merser. 1990. Rapid release of gentamicin from collagen sponge: In vitro comparison with plastic beads. Acta Orthop. Scand. 61(4):353-356.
143. Sripriya, R., M. S. Kumar, and P. K. Sehgal. 2004. Improved collagen bilayer dressing for the controlled release of drugs. J. Biomed. Mater. Res. B 70(2):389-396.
144. Sripriya, R., M. S. Kumar, M. R. Ahmed, and P. K. Sehgal. 2007. Collagen bilayer dressing with ciprofloxacin, an effective system for infected wound healing. J. Biomater. Sci. Polym. Ed. 18(3):335-351.
145. Stenzel, K. H., T. Miyata, and A. L. Rubin. 1974. Collagen as a biomaterial. Ann. Rev. Biophys. Bioeng. 3:231-253.
146. Stemberger, A., M. Unkauf, D. E. Arnold, and G. Blumel. 1990. Drug carrier systems based on resorbable polyester collagen and/or biomaterial combinations. In Cosmetic and Pharmaceutical Applications of Polymers, 263-268. C. G. Gebelein, T. C. Cheng, and C. C.-M. Yang, eds. New York, N. Y.: Plenum Press.
147. Stemberger, A., H. Grimm, F. Bader, H. D. Rahn, and R. Ascherl. 1997. Local treatment of bone and soft tissue infections with the collagen gentamicin sponge. European J. Surg. 578 (supp. 163):17-26.
148. Suh, J. K., and H. W. Matthew. 2000. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review. Biomaterials 21(24):2589-2598.
149. Supp, A. P., R. R. Wickett, V. B. Swope, M. D. Harriger, S. B. Hoath, and S. T. Boyce. 1999. Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice. Wound Repair Regen. 7(4):226-237.
150. Tabata, Y., and Y. Ikeda. 1989. Synthesis of gelatin microspheres containing interferon. Pharm. Res. 6(5):422-427.
151. Takeishi, H., K. Irie, K., Okuda, H. Ozawa, T. Yajima, and S. Ejiri. 2001. Molded bone augmentation of barrier membrane and recombinant human bone morphogenetic protein-2. Oral Dis. 7(5):281-286.
152. Tan, J., and M. Saltzman. 1999. Influence of synthetic polymers on neutrophil migration in three-dimensional collagen gels. J. Biomed. Mater. Res. A 46(4):465.
153. Tan, W., R. Krishnaraj, and T. A. Desai. 2001. Evaluation of nanostructured composite collagen-chitosan matrices for tissue engineering. Tissue Eng. 7(2):203-210.
154. Tay, B. K., A. X. Le, M. Heilman, J. Lotz, and D. S. Bradford. 1998. Use of a collagenhydroxyapatite matrix in spinal fusion: A rabbit model. Spine 23(21):2276-2281. (Pubitemid 28518573)
155. Thacharodi, D., and K. P. Rao. 1995. Collagen-chitosan composite membranes for controlled release of propranolol hydrochloride. Intl. J. Pharm. 120(1):115-118.
156. Thacharodi, D., and K. P. Rao. 1996. Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: Development and in vitro evaluations. Biomaterials 17(13):1307-1311.
157. Thaller, S., H. James, D. Andrew, B. Karen, and T. H. Sacramento. 1994. Repair of experimental calvarial defects with Bio-Oss particles and collagen sponges in a rabbit model. J. Cranio Maxill. Surg. 5(4):242-246.
158. Van der Rest, W. J., B. Dublet, and M. Champliaud. 1990. Fibril-associated collagens. Biomaterials 11 (proc.): 28-31.
159. Visser, R., P. M. Arrabal, J. Becerra, U. Rinas, and M. Cifuentes. 2009. The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo. Biomaterials 30(11):2032-2037.
160. Wachol-Drewek, Z., M. Pfeiffer, and E. Scholl. 1996. Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 17(17):1733-1738.
161. Wahlig, H., and E. Dingeldein. 1986. A new flavonoidic gentamicin salt providing a controlled sustained release of the antibiotic from biomaterials. In Proc. European Cong. Biomater., 196. Bologna, Italy.
162. Walsh, W. R., J. Harrison, A. Loefler, T. Martin, D. V. Sickle, M. K. C. Brown, and D. H. Sonnabend. 2000. Mechanical and histologic evaluation of Collagraft in an ovine lumbar fusion model. Clin. Orthop. 375:258-266.
163. Wedge, C. I., and D. S. Rootman. 1992. Collagen shields: Efficacy, safety, and comfort in the treatment of human traumatic corneal abrasion and effect on vision in healthy eyes. Canadian J. Ophthalmol. 27(6):295-298.
164. Weinberg, C. B., and E. Bell. 1986. A blood vessel model constructed from collagen and cultured vascular cells. Science 231(4736):397-400.
165. Willoughby, C. E., M. Batterbury, and S. B. Kaye. 2002. Collagen corneal shields. Surv. Ophthalmol. 47(2):174-182.
166. Wisser, D., and J. Steffes. 2003. Skin replacement with a collagen-based dermal substitute, autologous keratinocytes and fibroblasts in burn trauma. Burns 29(4):375-380.
167. Yamada, N., E. Uchinuma, and Y. Kuroyanagi. 1999. Clinical evaluation of an allogenic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix. Scandinavian J. Plast. Reconstr. Surg. Hand Surg. 33(2):147-154. (Pubitemid 29366693)
168. Yang, C. H. 2008. Evaluation of the release rate of bioactive recombinant human epidermal growth factor from crosslinking collagen sponges. J. Mater. Sci.: Mater. Med. 19(3):1433-1440.
169. Yang, C., P. J. Hillas, J. A. Baez, M. Nokelainen, J. Balan, J. Tang, R. Spiro, and J. W. Polarek. 2004. The application of recombinant human collagen in tissue engineering. Biodrugs 18(2):103-119.
170. Yannas, I. V., E. Lee, D. P. Orgill, E. M. Skrabut, and G. F. Murphy. 1989. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc. Natl. Acad. Sci. 86(3):933-937.
171. Yost, M. J., C. F. Baicu, C. E. Stonerock, R. I. Goodwin, R. I. Price, J. M. Davis, H. Evans, P. D. Watson, M. Gore, J. Sweet, L. Creech, M. R. Zile, and L. Terracio. 2004. A novel tubular scaffold for cardiovascular tissue engineering. Tissue Eng. 10 (1-2): 273-284.
172. Zeugolis, D. I., R. G. Paul, and G. Attenburrow. 2008. Extruded collagen-polyethylene glycol fibers for tissue engineering applications. J. Biomed. Mater. Res. B 85(2):343-352. (Pubitemid 351611626)